Capital International Sarl Has $16.13 Million Holdings in Corteva, Inc. $CTVA

Capital International Sarl lessened its stake in shares of Corteva, Inc. (NYSE:CTVA) by 36.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 240,574 shares of the company’s stock after selling 136,628 shares during the period. Capital International Sarl’s holdings in Corteva were worth $16,126,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Annis Gardner Whiting Capital Advisors LLC grew its stake in Corteva by 9.1% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock valued at $112,000 after acquiring an additional 140 shares in the last quarter. Drive Wealth Management LLC grew its stake in Corteva by 3.8% during the 4th quarter. Drive Wealth Management LLC now owns 4,259 shares of the company’s stock valued at $285,000 after acquiring an additional 156 shares in the last quarter. Reynders McVeigh Capital Management LLC grew its stake in shares of Corteva by 2.9% in the 4th quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company’s stock valued at $381,000 after buying an additional 160 shares in the last quarter. Chesapeake Capital Corp IL grew its stake in shares of Corteva by 0.9% in the 4th quarter. Chesapeake Capital Corp IL now owns 18,035 shares of the company’s stock valued at $1,209,000 after buying an additional 161 shares in the last quarter. Finally, Fox Run Management L.L.C. grew its stake in shares of Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after buying an additional 164 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of NYSE CTVA opened at $77.06 on Friday. The business has a fifty day simple moving average of $81.17 and a 200 day simple moving average of $74.94. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $51.54 billion, a price-to-earnings ratio of 45.33, a PEG ratio of 2.36 and a beta of 0.57. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same period in the prior year, the company posted $1.13 earnings per share. Corteva’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is 42.35%.

Analysts Set New Price Targets

CTVA has been the subject of several recent research reports. BNP Paribas Exane boosted their price target on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Mizuho boosted their target price on Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Wells Fargo & Company boosted their target price on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Finally, Berenberg Bank upped their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.